Synthelis – cell-free systems

Synthelis is a French biotech company specialized in production, purification and characterization of membrane proteins and other difficult-to-express proteins such as ion channel, membrane transporter, GPCR, membrane enzyme and antigen.

Synthelis – cell-free systems

synthelis

Continue reading

Mymetics – virosomes based vaccines

Mymetics is developing preventative vaccines using both virosomes as an effective adjuvant and vaccine delivery method, and an innovative antigen design to generate mucosal antibodies.

Mymetics – virosomes based vaccines

Mymetics Continue reading

XstalBio – bioformulation

XstalBio tackles challenging biologic formulations (required dosing too frequent, controlled release of API required, competitors hold blocking formulation patents, better adjuvant needed for target antigens, etc… ).

XstalBio – bioformulation

XstalBio Continue reading

Immunovaccine – cancer immunotherapies

Immunovaccine develops cancer immunotherapies and infectious disease vaccines based on a patented formulation providing controlled and prolonged exposure of antigens and adjuvant to the immune system : DepoVax.

Immunovaccine – cancer immunotherapies

IMV immunovaccine Continue reading